Amdocs (NASDAQ:DOX – Get Rating) was upgraded by StockNews.com from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Thursday. Separately, JPMorgan Chase & Co. downgraded shares of Amdocs from an “overweight” rating to a “neutral” rating and decreased their price objective for the stock from $91.00 to $86.00 […]